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Voltage-gated L-type Ca2+ channels (L-VGCCs) like CaV1.2 are assumed to play a crucial
role for controlling release of trophic peptides including brain-derived neurotrophic factor
(BDNF). In the inner ear of the adult mouse, besides the well-described L-VGCC CaV1.3,
CaV1.2 is also expressed. Due to lethality of constitutive CaV1.2 knock-out mice, the
function of this ion channel as well as its putative relationship to BDNF in the auditory
system is entirely elusive. We recently described that BDNF plays a differential role for
inner hair cell (IHC) vesicles release in normal and traumatized condition. To elucidate a
presumptive role of CaV1.2 during this process, two tissue-speciﬁc conditional mouse
lines were generated. To distinguish the impact of CaV1.2 on the cochlea from that on
feedback loops from higher auditory centers CaV1.2 was deleted, in one mouse line, under
the Pax2 promoter (CaV1.2Pax2) leading to a deletion in the spiral ganglion neurons, dorsal
cochlear nucleus, and inferior colliculus. In the second mouse line, the Egr2 promoter
was used for deleting CaV1.2 (CaV1.2Egr2) in auditory brainstem nuclei. In both mouse
lines, normal hearing threshold and equal number of IHC release sites were observed.
We found a slight reduction of auditory brainstem response wave I amplitudes in the
CaV1.2Pax2 mice, but not in the CaV1.2Egr2 mice. After noise exposure, CaV1.2Pax2 mice
had less-pronounced hearing loss that correlated with maintenance of ribbons in IHCs
and less reduced activity in auditory nerve ﬁbers, as well as in higher brain centers at
supra-threshold sound stimulation. As reduced cochlear BDNF mRNA levels were found
in CaV1.2Pax2 mice, we suggest that a CaV1.2-dependent step may participate in triggering
part of the beneﬁcial and deteriorating effects of cochlear BDNF in intact systems and
during noise exposure through a pathway that is independent of CaV1.2 function in efferent
circuits.
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INTRODUCTION
Activity-dependent gene transcription is functionally relevant for
animals to acquire information and adapt to the environment. One
major ion involved in transducing neuronal activity and regulating
transcription is calcium (Ca2+). Ca2+ inﬂux through voltage-
gated Ca2+ channels (VGCCs) serves as a key transducer coupling
changes in cell surface membrane potential with local intracel-
lular Ca2+ pathways. Among the L-type VGCCs (L-VGCCs),
CaV1.2 is also expressed in the organ of corti (Green et al., 1996;
Waka et al., 2003) and the brain (Catterall, 2000; Zuccotti et al.,
2011). In the brain, CaV1.2 is assumed to participate in altering
synapse efﬁcacy through transcriptional control of brain-derived
neurotrophic factor (BDNF; Tabuchi et al., 2000; Zuccotti et al.,
2011). The BDNF transcription is highly responsive to neural
activity. It is up-regulated by learning (Hall et al., 2000; Lubin
et al., 2008), physical exercise (Neeper et al., 1995), and kindling
or kainate-induced seizures (Dugich-Djordjevic et al., 1992). The
L-VGCCs contribute to the asynchronous release of neurotrophins
like BDNF from individual vesicles (Barg et al., 2002; Kolarow
et al., 2007), which is most probably CaV1.2 dependent (Kolarow
et al., 2007). Accordingly, Ca2+ entering the cell, either through
CaV1.2 or N-methyl-D-aspartate (NMDA) receptors can differen-
tially activate the BDNF promoter IV (Zheng et al., 2011), which
controls one of the eight untranslated 5′BDNF exons (exon I-VIII)
upstream of a common 3′BDNF exon IX that encodes the BDNF
protein (Aid et al., 2007). The BDNF transcribed from exon IV
is also expressed in the inner ear (Schimmang et al., 2003) and is
changed after ototoxic drug treatment through Ca2+-responsive
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elements such as CaRF1 in cochlear neurons (Singer et al., 2008).
It is also found that BDNF is up-regulated following auditory
trauma (Tan et al., 2007). These observations may be related to the
contrasting roles of BDNF previously described in the intact or
injured cochlea (Zuccotti et al., 2012).
On the one side, BDNF plays a crucial role to upgrade complex-
ity of the inner hair cell (IHC) synapse, including maintenance of
mature IHC number of synaptic ribbons, electron-dense presy-
naptic specializations that tether synaptic vesicles for exocytosis at
the active zone (Fuchs, 2005; Moser et al., 2006; Schmitz, 2009)
in mice (Zuccotti et al., 2012) and zebraﬁsh (Mo and Nicolson,
2011). On the other side, BDNF is harmful when acoustic over-
stimulation damages the mature system (Zuccotti et al., 2012). As
IHC ribbons are crucial for precision of sound processing (Buran
et al., 2010) and IHC ribbon loss and deafferentation after acoustic
trauma is discussed in the context of age-dependent hearing loss,
hyperacusis, and tinnitus (Kujawa and Liberman, 2009; Lin et al.,
2011; Singer et al., 2013), the elucidation of the molecular basis of
these effects is of crucial clinical relevance. As CaV1.2 (Favereaux
et al., 2011) and BDNF up-regulation (Coull et al., 2005; Trang
et al., 2011) is also discussed in the context of pain, our ﬁndings
may contribute to the understanding of sensory pathology beyond
the auditory ﬁeld.
To elucidate to what extent CaV1.2 might participate in the
described roles of BDNF in the healthy and injured cochlea,
we analyzed CaV1.2 function following conditional deletion of
CaV1.2 in the auditory system. This approach is essential as mice
globally lacking CaV1.2 die in utero before day 15 post-coitum
(Seisenberger et al., 2000). We conditionally inactivated CaV1.2
in the auditory system using the same Cre transgenic mouse line
as used for deletion of BDNF (Zuccotti et al., 2012). As feedback
loops from higher auditory centers, known as the corticofugal
pathway (Feliciano and Potashner, 1995), have been shown to
modulate directly efferent feedback along the descending auditory
pathway as well as the IHC in a frequency-speciﬁc way (Xiao and
Suga, 2002), we studied mice with an inactivation of CaV1.2 in the
superior olivary complex (SOC) that represent the second cen-
tral auditory processing center in the ascending auditory pathway,
using the Cre expression under the Egr2 promoter (Voiculescu
et al., 2000; Satheesh et al., 2012).
Both CaV1.2Pax2 and CaV1.2Egr2 conditional knock-out (KO)
mice were viable and thus could be analyzed for hearing capabil-
ity, sound processing along the ascending auditory pathway, and
sensitivity to noise exposure. We demonstrate here that CaV1.2 is
neither required in the cochlea nor in the SOC for normal IHC
or outer hair cell (OHC) function, thus suggesting that BDNF
function in normal IHC physiology (Zuccotti et al., 2012) does
not depend on CaV1.2. In contrast, loss of CaV1.2 in the cochlea,
but not in the SOC, partially mimics the described harmful BDNF
effect during acoustic trauma, a feature that could be linked to
reduced BDNF mRNA levels in cochlear tissue of CaV1.2Pax2 mice.
The results are discussed in the context of a role of L-type Ca2+
channels for BDNF release during cochlear injury.
MATERIALS AND METHODS
Care and use of animals and the experimental protocol were
reviewed and approved by animal welfare commissioner and the
regional board for scientiﬁc animal experiments in Tübingen,
Germany.
GENERATION OF CONDITIONAL KNOCK-OUT MICE
The conditional CaV1.2 knock-out mice CaV1.2Pax2 KO were gen-
erated by breeding mice carrying the ﬂoxed CaV1.2 allele (L2;
Seisenberger et al., 2000) with mice expressing Cre under control
of Pax2 regulatory regions (Ohyama and Groves, 2004) carrying
one ﬂoxed CaV1.2 allele (L1; Seisenberger et al., 2000), resulting
in cochlea-speciﬁc CaV1.2Pax2 KO mice (CaV1.2 L1/L2, Pax2::Cre)
and control animals (CaV1.2+/L2, Pax2::Cre). Besides the cochlea,
CaV1.2 was deleted in the dorsal cochlear nucleus (DCN), inferior
colliculus (IC), and the cerebellum in these mice (Ohyama and
Groves, 2004; Zuccotti et al., 2012).
The CaV1.2Egr2 KO mice were generated by breeding mice car-
rying ﬂoxed CaV1.2 alleles (L2; Seisenberger et al., 2000) with mice
carrying one CaV1.2 KO allele (L1; Seisenberger et al., 2000) and
expressing Cre from one allele of the Egr2 locus (Voiculescu et al.,
2000), which mediates recombination in rhombomeres 3 and 5
of the embryonic neural tube, allowing genetic manipulation of
neuronal populations such as the lateral superior olive (LSO) and
medial nucleus of the trapezoid body (MNTB) but not in the
cochlea, obtaining a speciﬁc knock-out in the LSO and MNTB
(Voiculescu et al., 2000; Rosengauer et al., 2012; Satheesh et al.,
2012).
HEARING MEASUREMENTS: AUDITORY BRAINSTEM RESPONSE AND
DISTORTION PRODUCT OTOACOUSTIC EMISSION
Auditory brainstem response (ABR), evoked by short-duration
sound stimuli, represents the summed activity of neurons in
distinct anatomical structures or nuclei along the ascending audi-
tory pathway (Burkard and Don, 2007) and is measured by
averaging the evoked electrical response recorded via subcuta-
neous electrodes. The ABR to click and pure tone stimuli and
the cubic 2 × f1 − f2 distortion product of the otoacoustic
emission (DPOAE) for f2 = 1.24 × f1 and L2 = L1 - 10 dB
were recorded in anesthetized mice aged 6–9 weeks. All physi-
ological recordings were performed under anesthesia [75 mg/kg
ketamine hydrochloride (Ketavet, Pharmacia, Pﬁtzer, Karlsruhe,
Germany), 5 mg/kg xylazine hydrochloride (Rompun 2%, Bayer
Leverkusen, Germany), 0.2 mg/kg atropine (Atropinsulfat B.
Braun, Melsungen, Germany)] in a soundproof chamber (IAC,
Niederkrüchten, Germany) as previously described (Engel et al.,
2006). In short, ABR thresholds were determined with click
(100 μs), and pure tone (2–45.3 kHz, 3 ms duration) stimuli.
OHC function was assessed by the DPOAE thresholds evoked
by stimuli at various frequencies (f2 = 4–32 kHz with half-
octave steps) and growth function of the DPOAE evoked by
f2 = 11.3 kHz.
NOISE EXPOSURE
For noise exposure, animals were exposed to broadband noise (4–
16 kHz, 120 dB sound pressure level (SPL) for 1 h) as previously
described (Engel et al., 2006) while under anesthesia (see above),
and supplemental doses of anesthetics were administered subcu-
taneously every 20 min. Sham-exposed animals were anesthetized
and placed in the reverberating chamber, but not exposed to
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acoustic stimulus (i.e., the speaker remained turned off). In noise-
exposed mice, the degree of the ABR threshold shift was measured
more than 7 days after noise exposure, when noise-induced per-
manent threshold shift (PTS; Liberman, 1980; Salvi et al., 1986)
have settled and a recovery from damage is no longer expected.
The sham-exposed animals have completely normal hearing.
TISSUE PREPARATION
For immunohistochemistry, cochleae were isolated, ﬁxed by
immersion in 2% paraformaldehyde, 125 mM sucrose in 100 mM
phosphate-buffered saline, pH 7.4, for 2 h, and then decalciﬁed
for 45 min in RDO rapid decalciﬁer (Apex Engineering Products
Corporation, Aurora, IL, USA) as previously described (Knipper
et al., 1999; Zuccotti et al., 2012; Singer et al., 2013), cryosec-
tioned at 10 μm, mounted on SuperFrost*/plus microscope slides
at −20◦C.
For RNA and proteins isolation, cochleae and different brain
regions were dissected with small forceps and immediately frozen
in liquid nitrogen and stored at −80◦C until use.
RNA ISOLATION, cDNA SYNTHESIS, AND REAL-TIME PCR
For real-time polymerase chain reaction (PCR) analysis, RNA
from mouse cochlea was isolated using the RNeasy mini
kit (QIAGEN, Hilden, Germany) following the manufac-
turer’s instructions. After reverse transcription using Sensis-
cript RT kit (QIAGEN), real-time PCR was performed using
the iCycler iQ detection system (Bio-Rad, Munich, Ger-
many). The real-time PCR reaction was set up following
the manufacturer’s instruction (QuantiFast SYBR Green, QIA-
GEN). The following primers were used: BDNF quantiﬁca-
tion, for 5′-GAAGCAAACGTCCACGGACAA-3′ and rev 5′-
AACCTTCTGGTCCTCATCCAG-3′; β-actin quantiﬁcation, used
as housekeeping gene, for 5′-GAATCCTGTGGCATCCATGA-3′
and rev 5′-CATCTGCTGGAAGGTGGACA-3′. The PCRprogram,
according to the manufacturer’s instructions, included an initial
activation step at 95◦C for 5 min, followed by 40 cycles of a
10-s lasting denaturing step at 95◦C and a 30-s combined anneal-
ing/extension step at 60◦C; all temperature transition rates were
1–3◦C/s. At the endof each cycle, the ﬂuorescence emitted by SYBR
Green was measured. At the end of the PCR reaction, samples
were subjected to a temperature ramp (from 70 to 95◦C, 2◦C/s)
with continuous ﬂuorescence monitoring for melting curve anal-
ysis. For each PCR product, a single narrow peak was obtained
by melting curve analysis at the speciﬁc temperature. Each sam-
ple was assayed in triplicate and the analysis was performed with
GeneExpressionMacro (version 1.1, Bio-Rad,Munich,Germany).
Samples containing no template were used as negative controls in
each experiment. Data were normalized to the housekeeping gene
expression level and presented as a percentage of the expression
relative to the control ± standard deviation (SD).
IMMUNOHISTOCHEMISTRY
For immunohistochemistry, mouse cochlear sections were stained
as previously described (Tan et al., 2007; Zuccotti et al., 2012;
Singer et al., 2013). The CtBP2/RIBEYE, mouse (BD Transduc-
tion Laboratories, USA); Otoferlin, rabbit (Schug et al., 2006);
and CaV1.2, rb (Hell et al., 1993) were used as primary antibodies.
For double labeling studies, both antibodies were simultaneously
incubated for identical time periods. Sections were viewed, as pre-
viously described (Zampini et al., 2010), using an Olympus BX61
microscope equipped with epiﬂuorescence illumination. Images
were acquired using an Olympus XM10 CCD monochrome cam-
era and analyzed with cellSens Dimension software (OSIS GmbH,
Munster, Germany). To increase spatial resolution, slices were
imaged over a distance of 15 μm within an image-stack along the
z-axis (z-stack) followed by 3-dimensional deconvolution using
cellSens dimension built-in algorithm.
NORTHERN BLOT
The mRNA isolation was performed using the Oligotex Direct
mRNA Mini Kit (QIAGEN). The mRNA was loaded onto a dena-
turing 0.8%agarose formaldehyde gel and transferred onto a nylon
membrane (Roche, Mannheim, Germany). The membrane was
blocked for 30 min at 65◦C with hybridization buffer, digoxigenin
Easy Hyb (Roche), and hybridized overnight at 65◦C with ribo-
probes for BDNF and cyclophilin. After washing, a 1-h blocking
step was performed. The membrane was incubated with anti-Dig-
AP (Roche; 1:20,000). The mRNA was detected with CDP-Star
ready-to-use (Roche) and exposed to X-ray ﬁlms.
WESTERN BLOT
Western blot with the antibody CNC1, which is directed against
Loop II/III of α1 1.2, the central CaV1.2 subunit, was performed as
previously described (Hell et al., 1993; Davare et al., 1999). Brieﬂy,
tissue samples were extracted with 3× sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer
at 90◦C for 5 min before SDS-PAGE in 7.5% polyacrylamide
gels, transfer to polyvinylidene diﬂuoride (PVDF) membranes,
blocking with 10% milk powder and detection with CNC1 and
horseradish peroxidase-coupled protein A. Tubulin with an anti-
tubulin monoclonal mouse antibody (Santa Cruz sc-5286, Dallas,
TX, USA) was detected in parallel at the lower part of the blot to
ensure equal loading when indicated.
DATA ANALYSIS
ABR waveform amplitude analysis
The ABR waveforms were analyzed for consecutive amplitude
deﬂections (waves), each wave consisting of a starting negative
(n) peak and the following positive (p) peak. Peak amplitudes of
ABRwaves I and IIIwere extracted in the present study anddeﬁned
as follows: wave I: In − Ip (0.9–2 ms), wave III: IIIn − IIIp (3.3–
4.1 ms). A customized program was used for the extraction of ABR
peaks based on the deﬁnitions given above. ABR peak-to-peak,
or wave amplitude growth functions were constructed for indi-
vidual ears based on the extracted peaks for increasing stimulus
levels. All ABR wave amplitude growth functions were calculated
for increasing stimulus levels with reference to the ABR thresh-
olds (from −20 to a maximum of 75 dB above threshold before
noise exposure and from −20 to a maximum of 55 dB above
threshold after noise exposure). For illustration purpose, ABR
wave amplitude growth functions as shown in Figures 3A,B,D,E
and 6A,B were ﬁrst linearly interpolated to the resolution of 1
data point/dB and then smoothed by a moving zero-phase Gaus-
sian ﬁlter with a window length of 9 data points. The ABR
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waveforms shown in the inset of the ﬁgures were smoothed by a
moving zero-phase Gaussian ﬁlter with a window length of 5 data
points (0.5 ms).
Statistical analysis
Unless otherwise stated, all data were presented as group mean
with SD or with standard error of the mean (SEM). Differ-
ences of the means were compared for statistical signiﬁcance
either by Student’s t-test, one-way, or two-way ANOVA tests. The
ANOVA tests were followed by multiple t-tests with Bonferroni–
Holm’s adjustment of α levels. Statistical signiﬁcance was tested
at the level α = 0.05, and resulting p values are reported in
the legends. *p < 0.05; **p < 0.01; ***p < 0.001; n.s., not
signiﬁcant.
RESULTS
CONDITIONAL DELETION OF CaV1.2 DRIVEN BY THE Pax2 AND Egr2
PROMOTERS
Tocircumvent embryonic lethality of mice globally lackingCaV1.2,
CaV1.2 loxP/loxP (or ﬂoxed) mice (Seisenberger et al., 2000) were
either mated to Pax2::Cre mice (Ohyama and Groves, 2004) or to
Egr2::Cre mice (Voiculescu et al., 2000).
As predicted for the usage of Cre under control of the Pax2
promoter (Ohyama and Groves, 2004; Zuccotti et al., 2012),
CaV1.2Pax2 KO mice exhibited a deletion of CaV1.2 in the cochlea,
brainstem, and cerebellum,butnot in the auditory cortex. Thiswas
detected by Western blot analysis [Figure 1A, n = 10 cochleae (5
mice), 2 brainstem (2 mice), 2 cerebella (2 mice), 2 auditory cortex
(2 mice); experiments done in triplicate]. The deletion of CaV1.2
in spiral ganglion neurons (SGNs; Warr and Guinan, 1979) was
conﬁrmed by immunohistochemistry (Figure 1B, CaV1.2, red).
No CaV1.2 staining was observed in CaV1.2Pax2 KO animals in
comparison to control littermates (Figure 1B, red).
Usage of Cre under the control of the Egr2 promoter leads
to a knock-out of CaV1.2 in the SOC forming part of the audi-
tory brainstem (Voiculescu et al., 2000; Rosengauer et al., 2012;
Satheesh et al., 2012). This was conﬁrmed by Western blot of
the SOC (n = 3 control mice, 3 KO mice; experiments done in
triplicate) where no CaV1.2 expression was detected (Figure 1C).
HEARING FUNCTION IN CaV1.2 MOUSE LINES
To test whether the lack of CaV1.2 in the cochlea or brainstem
affects hearing function at adult stages, ABR and DPOAE in 2- to
4-month-old mice were measured.
For the CaV1.2Pax2 mice, no signiﬁcant difference was observed
compared to controls for click-evokedABR thresholds (Figure 2A,
CaV1.2Pax2 control: 15.6 ± 2.97 dB SPL; CaV1.2Pax2 KO:
16.2 ± 2.71 dB SPL; n = 16 ears, 8 mice each, two-sided Student’s
t-test: p = 0.556) or tone-burst evokedABR thresholds (Figure 2B,
CaV1.2Pax2 control: n = 7–8 ears, 7–8 mice; CaV1.2Pax2 KO: n = 6–
8 ears, 6–8 mice, two-wayANOVA,p = 0.890). Similar results were
obtained for the CaV1.2Egr2 mouse line for click-evoked stim-
uli (Figure 2E, CaV1.2Egr2 control: 13.2 ± 2.20, n = 16 ears, 8
mice; CaV1.2Egr2 KO: 14.7 ± 4.28, n = 18 ears, 9 mice, two-sided
Student’s t-test: p = 0.204) and tone-burst evoked ABR thresh-
olds (Figure 2F, CaV1.2Egr2 control: n = 12–13 ears, 8–9 mice;
CaV1.2Egr2 KO: n = 13 ears, 9 mice, two-way ANOVA, p = 0.132).
Since OHC electromotility codetermines the sound-evoked
neural potentials at threshold (El-Badry and McFadden, 2007),
DPOAE were measured as an objective indicator of OHC func-
tion. TheDPOAE thresholds (Figures 2C,G) and the input/output
(I/O) function of emission amplitudes evoked by stimulus fre-
quency of 11.3 kHz (Figures 2D,H), the frequency showing the
best hearing sensitivity for the mice, were found to be similar
between control and CaV1.2Pax2 KO mice (CaV1.2Pax2 control:
n = 4 ears, 4 mice; CaV1.2Pax2 KO: n = 4 ears, 4 mice, two-
way ANOVA, p = 0.452) and CaV1.2Egr2 KO (CaV1.2Egr2 control:
n = 14–15 ears, 8 mice; CaV1.2Egr2 KO: n = 16–18 ears, 9
mice), indicating that loss of CaV1.2 did not inﬂuence motility
of OHCs.
The click-evoked ABR waveform amplitudes are expected to
change proportionally to the size of discharge rates and number
of synchronously ﬁring auditory nerve (AN) ﬁbers (Johnson and
Kiang, 1976). We, therefore, analyzed ABR wave I (Figures 3A,D),
FIGURE 1 |Tissue-specific deletion of CaV1. 2 in CaV1.2
Pax2 KO and
CaV1.2
Egr2 KO mice. (A)Western blot for CaV1.2 protein (230 and 190 kDa
proteolytic product) in mouse cochlea (Co), brainstem (BS), cerebellum (Ce),
and cortex (Cx) from control and CaV1.2
Pax2 KO mice. No CaV1.2 protein
was detected in tissues from KO mice, with the exception for the cortex
where the Cre-mediated recombination does not occur [n = 10 cochleae
(5 mice), 2 brainstem (2 mice), 2 cerebella (2 mice), 2 auditory cortex
(2 mice); experiments done in triplicate]. (B) Immunoﬂuorescent labeling
of CaV1.2 in spiral ganglion neurons from control mice (left), shown
at higher magniﬁcation (insert) and CaV1.2
Pax2 KO mice (right) using
an antibody against CaV1.2 (red). Nuclei were counterstained with
4′,6-diamidino-2-phenylindole (DAPI; blue). (C)Western blot for CaV1.2
protein (230 kDa) and tubulin (60 kDa) in control and CaV1.2
Egr2 KO
mice conﬁrming the deletion of CaV1.2 in the superior olivary complex
(SOC; n = 3 control mice, 3 KO mice; experiments done in
triplicate).
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FIGURE 2 | Continued
FIGURE 2 | Continued
No deterioration of ABR thresholds and OHC function in CaV1.2
Pax2 KO
and CaV1.2
Egr2 KO mice. (A) Mean ± SD click-evoked ABR (click-ABR)
thresholds for CaV1.2
Pax2 control (black horizontal dash, single ear
thresholds as white circles) and CaV1.2
Pax2 KO mice (red horizontal dash,
single ear thresholds as red squares). Thresholds were not signiﬁcantly
different (two-sided Student’s t -test: p = 0.556) between KO mice
(16.2 ± 2.71, n = 16 ears, 8 mice) and control (15.6 ± 2.97, n = 16 ears,
8 mice). (B) Mean ± SD tone-burst-evoked ABR (f-ABR) thresholds for
CaV1.2
Pax2 KO mice (red) and controls (white). Thresholds were not
signiﬁcantly different (two-way ANOVA, p = 0.890) between KO mice
(n = 6–8 ears, 6–8 mice) and controls (n = 7–8 ears, 7–8 mice).
(C) Mean ± SD DPOAE thresholds for CaV1.2Pax2 control mice (control,
white) and CaV1.2
Pax2 KO mice (KO, red). Thresholds were not signiﬁcantly
different (two-way ANOVA: p = 0.452) between KO mice (n = 4 ears,
4 mice) and controls (n = 4 ears, 4 mice). (D) Mean ± SD DPOAE amplitude
I/O function evoked by stimulus f2 = 11.3 kHz for CaV1.2Pax2 KO mice (red)
and controls (white) showing no signiﬁcant difference (two-way ANOVA:
p = 0.158) between KO mice (n = 4 ears, 4 mice) and controls (n = 4 ears,
4 mice). (E) Mean ± SD click-ABR thresholds for CaV1.2Egr2 control mice
(black horizontal dash, single ear thresholds as white circles) and CaV1.2
Egr2
KO (green horizontal dash, single ear thresholds as green squares).
Thresholds were not signiﬁcantly different (two-sided Student’s t -test:
p = 0.204) between KO mice (14.7 ± 4.28, n = 18 ears, 9 mice) and
controls (13.2 ± 2.20, n = 16 ears, 8 mice). (F) Mean ± SD f-ABR
thresholds for CaV1.2
Egr2 KO mice (green) and controls (white). Thresholds
were not signiﬁcantly different (two-way ANOVA, p = 0.132) between KO
mice (n = 13 ears, 9 mice) and controls (n = 12–13 ears, 8–9 mice).
(G) Mean ± SD DPOAE thresholds for CaV1.2Egr2 KO mice (green) and
controls (CaV1.2
Egr2 control, white). Thresholds were not signiﬁcantly
different (two-way ANOVA: p = 0.195) between KO mice (n = 16–18 ears,
9 mice) and controls (n = 14–15 ears, 8 mice). (H) Mean ± SD DPOAE
amplitude I/O function evoked by stimulus f2 = 11.3 kHz for CaV1.2Egr2
KO mice (green) and controls (white) showing no signiﬁcant difference
(two-way ANOVA: p = 0.566) between KO mice (n = 16–18 ears, 9 mice)
and controls (n = 14–15 ears, 8 mice).
reﬂecting the summed activity of the AN ﬁbers, and ABR wave III
(Figures 3B,E), corresponding to the SOC(Melcher et al., 1996), in
the two CaV1.2 mutant mouse lines where CaV1.2 is missing either
in the cochlea or in parts of the auditory brainstem (Figure 1). In
CaV1.2Pax2 mice, but not in CaV1.2Egr2 mice, a stronger decline
of ABR wave I was observed beginning at 50 dB above threshold
(Figure 3A, CaV1.2Pax2 control: n= 3–6 ears, 3–6mice; CaV1.2Pax2
KO: n = 5–9 ears, 3–6 mice; two-way ANOVA, p = 0.048, post hoc
one-sided Student’s t-test: p = 0.049 at 65 dB above threshold, no
Bonferroni–Holm’s adjustment for multiple testing; Figure 3D,
CaV1.2Egr2 control: n = 12–13 ears, 7 mice; CaV1.2Egr2 KO: n = 7–
11 ears, 4–8 mice; two-way ANOVA: p = 0.784). No signiﬁcant
differences were observed for the amplitudes of ABR wave III
between KO mice (both CaV1.2Pax2 KO and CaV1.2Egr2 KO) and
the respective controls (Figures 3B,E).
Synaptic ribbons are known to be an accurate metric of the
afferent innervation of IHCs (Kujawa and Liberman, 2009) that
drive postsynaptic AN ﬁbers by a large releasable transmitter pool
(Matthews and Fuchs, 2010). The number of synaptic ribbons in
the CaV1.2Pax2 and CaV1.2Egr2 mouse lines (Figures 3C,F) was
not signiﬁcantly different observed along the different cochlear
turns [apical: 2–7 kHz, medial: 7–16 kHz, and midbasal:>17 kHz
(Müller, 1991)] between the mutant lines and their respective
controls (Figure 3C, control: n = 4 ears, 3 mice and CaV1.2Pax2
KO: n = 3 ears, 3 mice, two-way ANOVA: p = 0.260; Figure 3F,
controls: n = 3 ears, 3 mice, CaV1.2Egr2 KO: n = 3 ears, 3 mice,
two-way ANOVA: p = 0.446).
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FIGURE 3 | Reduction of ABR wave I amplitudes and unalteredABR wave
III amplitudes in CaV1.2
Pax2 KO mice. (A) Mean ± SEM click-
evoked ABR wave I amplitude growth function for CaV1.2
Pax2 control
(control, black line, and gray area) and CaV1.2
Pax2 KO mice (KO, red
squares). ABR wave I amplitudes were signiﬁcantly different (two-way
ANOVA, p = 0.048) between KO (n = 5–9 ears, 3–6 mice) and controls
(n = 3–6 ears, 3–6 mice), particularly at 65 dB above threshold (post hoc
one-sided Student’s t -test: p = 0.049, no Bonferroni–Holm’s adjustment for
multiple testing). The black and red waveforms in the inset depict
representative ABR traces measured from one individual ear of a CaV1.2
Pax2
control and a KO mouse, respectively, evoked at the level of 65 dB above the
hearing threshold. The leading negative (n) and following positive
(p) peak corresponded to wave I are indicated by an upward and a downward
pointing arrow head associated with symbols “In” and “Ip” respectively.
(B) Mean ± SEM click-evoked ABR wave III amplitude growth function for
controls and CaV1.2
Pax2 KO mice. ABR wave III amplitudes were not
signiﬁcantly different (two-way ANOVA, p = 0.639) between KO (n = 2–5
ears, 2–4 mice) and controls (n = 3 ears, 2 mice). The leading negative (n)
and following positive (p) peak corresponded to wave III are indicated by
arrow heads and marked “IIIn” and “IIIp” respectively. (C) Mean synaptic
ribbon number ± SD are not signiﬁcantly different (two-way ANOVA,
p = 0.260) between control and CaV1.2Pax2 KO mice in apical, medial,
and midbasal cochlear turns (control: n = 4 cochleae, 3 mice; KO: n = 3
cochleae, 3 mice). (D) Mean ± SEM click-evoked ABR wave I amplitude
growth function for CaV1.2
Egr2 KO mice (green squares) and controls
(CaV1.2
Egr2 control, black and gray area). ABR wave I amplitudes were not
signiﬁcantly different (two-way ANOVA, p = 0.784) between KO (n = 7–11
ears, 4–8 mice) and controls (n = 12–13 ears, 7 mice). The black and green
waveforms in the inset depict representative ABR traces measured from one
individual ear of a CaV1.2
Egr2 control mouse and KO mouse, respectively,
evoked at the level of 65 dB above the hearing threshold. (E) Mean ± SEM
click-evoked ABR wave III amplitude growth function for CaV1.2
Egr2 KO mice
and controls. ABR wave III amplitudes were not signiﬁcantly different
(two-way ANOVA, p = 0.281) between KO (n = 9–12 ears, 5–7 mice) and
controls (n = 10–11 ears, 6 mice). (F) Mean ± SD IHC ribbon counts for
CaV1.2
Pax2 control (control, white bars) and CaV1.2
Pax2 KO mice (KO, green
bars) in apical, medial, and midbasal cochlear turns. No signiﬁcant difference
(two-way ANOVA, p = 0.446) between the number of ribbons in control
and CaV1.2
Egr2 KO mice (control: n = 3 cochleae, 3 mice; KO: n = 3 cochleae,
3 mice).
ACOUSTIC TRAUMA EFFECT ON HEARING FUNCTION IN CONDITIONAL
CaV1.2 MUTANTS
We studied a possible role of CaV1.2 during noise damage by
comparing ABR thresholds between control and CaV1.2Pax2 KO
and CaV1.2Egr2 KO mice after exposing them for 1 h to broadband
noise (4–16 kHz) of 120 dB SPL.Hearing thresholds were analyzed
byABR to click stimulus 7–11 days after noise exposure (Figure 4).
All noise-exposed animals (controls and KOs) showed
signiﬁcant ABR threshold losses for click stimuli (Figures 4A,B;
Tables 1 and 2).
However, ABR thresholds to click stimuli were signiﬁcantly
lower in noise-exposed CaV1.2Pax2 KO mice in comparison
to noise-exposed controls after 7 days (Figure 4A; Table 1,
comparison between genotypes at 7 days post noise). On the
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FIGURE 4 | Mild loss of click-ABR threshold in CaV1.2
Pax2 KO mice after
noise exposure. (A) Mean ± SD click-ABR threshold losses for CaV1.2Pax2
controls (black horizontal dash, 45.3 ± 9.51, n = 16 ears, 8 mice, single ear
threshold losses as white circles) and CaV1.2
Pax2 KO mice (red horizontal
dash, 30.9 ± 8.87, n = 16 ears, 8 mice, single ear threshold losses as red
squares) 7 days after noise exposure showing a signiﬁcantly milder
threshold loss (14.5 dB difference; two-sided Student’s t -test: p < 0.001) in
CaV1.2
Pax2 KO mice. (B) Mean ± SD click-ABR threshold losses for
CaV1.2
Egr2 controls (black horizontal dash, 21.6 ± 16.8, n = 13 ears, 7 mice,
single ear threshold losses as white circles) and CaV1.2
Egr2 KO mice (green
horizontal dash, 17.2 ± 12.9, n = 16 ears, 8 mice, single ear threshold
losses as green squares) 7–11 days after noise exposure, showing similar
threshold loss (4.4 dB difference; two-sided Student’s t -test: p = 0.431).
Dotted lines at 0 dB represent no threshold loss after noise exposure.
contrary, no differences were observed between control and
CaV1.2Egr2 KOmice. Reduced vulnerability of click-ABR threshold
loss appeared instantaneously and was observed already at the ﬁrst
day after exposure (Figure 5), indicating that CaV1.2 deletion may
control a key event for threshold loss already shortly after the
induction of trauma.
These data suggest that CaV1.2 deletion in the cochlea, but not
in the brainstem, protects against noise.
Since signiﬁcant differences in hearing thresholds were
observed between CaV1.2Pax2 control and KO mice 7–11 days after
noise exposure, click-evoked ABR wave amplitude growth func-
tions were compared between control and CaV1.2Pax2 KO 7 days
after noise exposure for latencies corresponding to theAN (wave I)
Table 1 | Auditory brainstem response thresholds for CaV1.2Pax2
mouse line evoked by click stimuli.
Click-ABR threshold (dB SPL) Significance
Pre noise 7 days post noise
CaV1.2Pax2 control 15.6 ± 2.97 (16/8) 60.9 ± 8.90 (16/8) ***
CaV1.2Pax2 KO 16.2 ± 2.71 (16/8) 47.1 ± 8.84 (16/8) ***
Signiﬁcance n.s. ***
Mean ± SD (no. of ears/no. of mice); ***p < 0.001 (two-sided t-test); n.s., not
signiﬁcant.
Table 2 | Auditory brainstem response thresholds for CaV1.2Egr2 mouse
line evoked by click stimuli.
Click-ABR threshold (dB SPL) Significance
Pre noise 7–11 days
post noise
CaV1.2Egr2 control 13.2 ± 2.20 (16/8) 34.8 ± 15.70 (13/7) ***
CaV1.2Egr2 KO 14.7 ± 4.28 (18/9) 31.9 ± 12.80 (16/8) ***
Signiﬁcance n.s. n.s.
Mean ± SD (no. of ears/no. of mice); ***p < 0.001 (two-sided t-test); n.s.,
not signiﬁcant.
andSOC(wave III;Melcher et al., 1996). After noise exposure, both
ABR wave I (Figure 6A, CaV1.2Pax2 control: n = 5–11 ears, 5–8
mice; CaV1.2Pax2 KO: n = 6–13 ears, 5–8 mice; two-way ANOVA,
p = 0.004, post hoc one-sided Student’s t-test: p = 0.038 at 35 dB
above threshold, Bonferroni–Holm’s adjustment for multiple test-
ing; p = 0.026 at 40 dB above threshold, no Bonferroni–Holm’s
adjustment for multiple testing) and ABR wave III amplitudes in
CaV1.2Pax2 KO mice (Figure 6B, CaV1.2Pax2 control: n = 3–10
ears, 3–6 mice; CaV1.2Pax2 KO: n = 3–7 ears, 3–4 mice; two-way
ANOVA, p = 0.013) were less reduced when compared to the con-
trols at high stimulation levels of sound intensity (>30 dB above
thresholds).
The changes in the ABR wave I amplitude and the hearing
thresholds observed in CaV1.2Pax2 mutants were accompanied
by an altered number of synaptic ribbons in the three cochlear
regions (apical, medial, and midbasal). Ribbon numbers in noise
FIGURE 5 | Preservation of click-ABR thresholds in CaV1.2
Pax2 KO mice
after noise exposure. Mean ± SD click-ABR threshold losses for control
and CaV1.2
Pax2 KO mice before noise exposure, after noise exposure at the
same day, 1 day, 3 days, and 7 days, showing a signiﬁcant differences in
threshold losses (two-way ANOVA, p < 0.001) between control (14–16
ears, 7–8 mice) and KO (16 ears, 8 mice). Signiﬁcant differences in
threshold loss were observed at 3 days (post hoc two-sided Student’s
t -test: p = 0.007, Bonferroni–Holm’s adjustment for multiple testing) and
7 days (post hoc two-sided Student’s t -test: p < 0.001, Bonferroni–Holm’s
adjustment for multiple testing) after noise exposure.
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FIGURE 6 | Less reduction of ABR wave I and wave III amplitudes in
CaV1.2
Pax2 KO mice after noise exposure. (A) Mean ± SEM click-evoked
ABR wave I amplitude growth function for CaV1.2
Pax2 KO mice (red
squares) and controls (control, black line and gray area) 7 days after noise
exposure. ABR wave I amplitudes were signiﬁcantly different (two-way
ANOVA, p = 0.004) between KOs (n = 6–13 ears, 5–8 mice) and controls
(n = 5–11 ears, 5–8 mice), particularly at 35 dB (post hoc one-sided
Student’s t -test: p = 0.038, Bonferroni–Holm’s adjustment for multiple
testing) and 40 dB (post hoc one-sided Student’s t -test: p = 0.026, no
Bonferroni–Holm’s adjustment for multiple testing) above threshold. The
black and red waveforms in the inset depict ABR traces measured from
one individual ear of a CaV1.2
Pax2 control and KO mouse, respectively,
evoked at the level of 40 dB above the hearing threshold. The leading
negative (n) and following positive (p) peak corresponded to wave I are
indicated by arrow heads and marked “In” and “Ip” respectively.
(B) Mean ± SEM click-evoked ABR wave III amplitude growth function for
CaV1.2
Pax2 KO mice and controls. ABR wave III amplitudes were
signiﬁcantly different (two-way ANOVA, p = 0.013) between KOs (n = 3–7
ears, 3–4 mice) and controls (n = 3–10 ears, 3–6 mice). The leading
negative (n) and following positive (p) peak corresponded to wave III are
indicated by arrow heads and marked “IIIn” and “IIIp” respectively.
(C) Mean ribbon counts ± SD of control and CaV1.2Pax2 KO before and
7 days after noise exposure showing reduction of the number of ribbons
between control mice before and after noise exposure at all three cochlear
turns, and was statistically signiﬁcant at the medial and the midbasal turns
(one-way ANOVA, apical turn p = 0.060, medial turn p = 0.026, midbasal
turn p = 0.047). However, reduction is mainly observed in the control mice
(before noise exposure: white bars, n = 4 cochleae, 4 mice; after noise
exposure: gray bars, n = 3 cochleae, 3 mice; post hoc two-sided Student’s
t -test with no Bonferroni–Holm’s adjustment for multiple testing for medial
turn: p = 0.018 and midbasal turn: p = 0.045) but not in the CaV1.2Pax2 KO
mice (before noise exposure: red bars, n = 3 cochleae, 3 mice; after noise
exposure: dark red bars, n = 3 cochleae, 3 mice; post hoc two-sided
Student’s t -test with no Bonferroni–Holm’s adjustment for multiple testing
for medial turn: p = 0.306 and midbasal turn: p = 0.773). Seven days after
noise exposure, larger number of ribbons are observed in CaV1.2
Pax2 KO
mice at all three cochlear turns and are signiﬁcantly larger at the medial turn
(post hoc two-sided Student’s t -test with no Bonferroni–Holm’s adjustment
for multiple testing, p = 0.004) and midbasal turn (post hoc two-sided
Student’s t -test with no Bonferroni–Holm’s adjustment for multiple testing,
p = 0.023) compared to control mice.
exposed CaV1.2Pax2 KO IHCs were slightly different in all cochlear
turns 7 days after exposure compared with the ribbon num-
bers in CaV1.2Pax2 KO mice, but were higher in comparison to
noise-exposed control mice (Figure 6C).
CaV1.2Pax2 KO MICE SHOW REDUCED BDNF LEVELS IN THE COCHLEA
We showed recently that BDNF controls the number of ribbon
synapses in cochlear IHCs and that its absence protects against
noise-induced damage (Zuccotti et al., 2012). Most strikingly, L-
VGCCs have been described to play a crucial role for activation of
nerve growth factor responsiveness in the brain (Aliaga et al., 1998;
Shieh et al., 1998; Tabuchi et al., 2000; West et al., 2001; Takeuchi
et al., 2002; Tao et al., 2002; Chen et al., 2003). We, therefore, ana-
lyzed BDNF levels in the cochleae of CaV1.2Pax2 KO mice through
real-time PCR and Northern blots using primers or riboprobes
spanning the BDNF protein coding exon IX. The CaV1.2Pax2 KO
mice showed a reduced expression of BDNF mRNA by real-time
PCR (Figure 7A, CaV1.2Pax2 control: n = 11 mice; CaV1.2Pax2 KO:
n = 10 mice, two-sided Student’s t-test: p = 0.006) and Northern
blot (Figures 7B,C, CaV1.2Pax2 control: n = 12 mice; CaV1.2Pax2
KO: n = 11 mice, two-sided Student’s t-test: p = 0.193 for 4.4 kb
and p = 0.043 for 1.8 kb), conﬁrming that BDNF expression is
regulated by CaV1.2 in the cochlea. The noise protection observed
may thus be explained by the reduced BDNF levels when CaV1.2
is deleted in the cochlea, similar to the situation in BDNFPax2 KO
mice (Zuccotti et al., 2012).
DISCUSSION
Werecently showed that lack of BDNFhampers IHC synapse phys-
iology andhearing functionwhile it protects against noise-induced
hearing loss (NIHL; Zuccotti et al., 2012). In the present study, we
provide evidence that part of this crucial BDNF expression may
be controlled by the L-VGCC CaV1.2.
CaV1.2 is expressed in SGN and efferent synapses (Waka et al.,
2003) that originate in the olivocochlear system in the brainstem
and terminate axo-dendritically on afferent type I ﬁbers and axo-
somatically on OHCs in the cochlea (White and Warr, 1983). The
expression pattern of CaV1.2 is mostly non-overlapping with that
of another L-VGCC,CaV1.3, that has been shown to play an essen-
tial role for hearing, since its deletion results in deafness (Platzer
et al., 2000).
CaV1.2 knock-out mice are lethal at birth and thus, the role of
CaV1.2 in hearing function is elusive. CaV1.2 is assumed to partic-
ipate in altering synapse efﬁcacy through transcriptional control
of BDNF (Tabuchi et al., 2000; Zuccotti et al., 2012).
According to West et al. (2001), Ca2+ inﬂux through CaV1.2
activates aCa2+ responsive bindingprotein,CaRF, that acts as a cis-
acting element on the BDNF exon IV promoter to control BDNF
transcription after, e.g., stimulation by kainate. In this study, we
analyzedmicewith a conditional deletion of CaV1.2 in the cochlea,
with Cre recombinase controlled by the Pax2 promoter as recently
described for the conditional BDNF KO mice in Zuccotti et al.
(2012). We, moreover, compared the effect of deletion of CaV1.2
in the SOC using mice with Cre recombinase controlled by Egr2
promoter (CaV1.2Egr2 KO mice).
By measuring ABR thresholds and DPOAE, where the DPOAE
reﬂect the functionality of the OHCs, we found that both
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FIGURE 7 | Reduced expression of BDNF in the cochlea of CaV1.2
Pax2
KO mice. (A) Real-time PCR of BDNF exon IX mRNA in the cochlea of
control (white bar) and CaV1.2
Pax2 KO mice (red bar), expressed as a
percentage of the control set to 100%, shows a signiﬁcant reduction of
the mRNA level in the KO mice (CaV1.2
Pax2 control: n = 11 mice; CaV1.2Pax2
KO: n = 10 mice, two-sided Student’s t -test: p = 0.006). (B) Northern
blot of control and CaV1.2
Pax2 KO mice cochlea showing the two BDNF
isoforms at 1.8 and 4.4 kb and cyclophilin as housekeeping gene at 0.8 kb.
(C) Quantiﬁcation of the Northern blot shows a signiﬁcant reduction of the
1.8 kb BDNF mRNA isoform, but not the 4.4 kb isoform in the cochlea of
CaV1.2
Pax2 KO mice (CaV1.2
Pax2 control, white bars: n = 12 mice; CaV1.2Pax2
KO, red bars: n = 11 mice, two-sided Student’s t -test: p = 0.193 for 4.4 kb
and p = 0.043 for 1.8 kb). Data are expressed as a percentage of control set
to 100%.
CaV1.2Pax2 KO and CaV1.2Egr2 KO mice do not display signiﬁcant
changes of thresholds andOHC function. This implies that CaV1.2
expression in the cochlea and SOC might not be essential for
maintenance of hearing thresholds and OHC function. Further-
more, we analyzed the ABR wave amplitudes, which reﬂect the
number of synchronously ﬁring neurons in distinct structures
and nuclei along the ascending auditory pathway (Burkard and
Don, 2007). Wave I amplitudes, corresponding to the neural activ-
ity from the AN ﬁbers (Johnson and Kiang, 1976), of CaV1.2Pax2
KO mice were found signiﬁcantly reduced starting at 50 dB above
threshold compared to the control mice. In contrast, wave III
amplitudes, corresponding to the neural activity from the cochlear
nucleus (CN) and the SOC in the lower brainstem (Melcher et al.,
1996), of the CaV1.2Pax2 KO mice are unchanged. Also wave I and
III amplitudes of CaV1.2Egr2 KO mice appeared normal.
This may indicate that, similar to the role of BDNF (Zuccotti
et al., 2012), lack of CaV1.2 in the cochlea hampers the function of
the AN, but the phenotype appears to be less pronounced.
Per contra to what has been described for the BDNF condi-
tional KO mice (Zuccotti et al., 2012), we could not ﬁnd signiﬁcant
differences in the number of ribbons in CaV1.2Pax2 KO mice. Rib-
bon structure in IHC maintains a large ready releasable pool
in IHCs and deﬁnes the reliability within spikes of auditory
ﬁbers (Buran et al., 2010). A reduced ABR wave I amplitude
was found only at high sound intensities, suggesting that the
lack of CaV1.2 in the CaV1.2Pax2 KO mice may alter the num-
ber of synchronously ﬁring AN ﬁbers that particularly respond
to high sound intensities. Indeed, at least two different afferent
ﬁber types exist: high spontaneous ﬁring rate (SR) ﬁbers with
greater sensitivities (low-response thresholds) and low SR ﬁbers
with less sensitivity (high-response thresholds; Liberman, 1980,
1982). ABR thresholds, depending on the responses of high SR
AN ﬁbers, were not affected in CaV1.2Pax2 KO mice, while AN
responses at high intensities were found to be reduced. Thus, we
hypothesize that CaV1.2 in the cochlea might contribute to the
neural responses of low SR AN ﬁbers. Future studies may test this
hypothesis.
It has been reported that prolonged noise exposure induces
various types of hearing damage in rodents, including loss of
threshold and disturbance of neural activity along the ascend-
ing auditory pathway (Kujawa and Liberman, 2009; Zuccotti et al.,
2012; Rüttiger et al., 2013; Singer et al., 2013). Recent studies sug-
gested that the trigger of the loss of SGN in the cochlea, after
an acoustic overstimulation, does not originate from IHCs but
rather from IHC supporting cells. In particular, inner border
and inner phalangeal cells have been proposed to be essential
for neuronal survival after IHC damage (Zilberstein et al., 2012).
These supporting cell types have also been shown to express
BDNF (Sobkowicz et al., 2002; Zuccotti et al., 2012). Around 7–
11 days after noise exposure, NIHL and a PTS were observed in
both CaV1.2Pax2 KO and CaV1.2Egr2 KO mouse lines. However,
the ABR threshold loss was signiﬁcantly less pronounced in the
CaV1.2Pax2 KO mouse mutants than in the CaV1.2Egr2 KO mice.
This indicates that deletion of CaV1.2 might reduce the vulner-
ability to acoustic trauma. A reduced vulnerability to acoustic
trauma was also observed recently upon deletion of BDNF under
the same Pax2 promoter as used here for CaV1.2 deletion (Zuc-
cotti et al., 2012). A ﬁrst hint that the phenotype of CaV1.2Pax2
KO and BDNFPax2 KO after acoustic trauma may be causally
related is yielded by the observation that BDNF mRNA is par-
tially reduced in the cochlea of CaV1.2Pax2 KO mice. The loss
of BDNF mRNA in CaV1.2Pax2 KO cochlea mainly affected the
short BDNF transcripts. Short and long BDNF transcripts result
from alternative 3′ end processing of the BDNF transcripts at 3′
untranslated regions (3′UTRs). Distinct RNA sequences in these
BDNF 3′UTRs are reported to differentially regulate neuronal
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activity changes through altered BDNF stability and translation
of these BDNF mRNA isoforms (Lau et al., 2010). While we are
far from understanding the role of different BDNF transcripts in
the cochlea, we may conclude that CaV1.2 controls short BDNF
transcripts. A selected function of CaV1.2 for short BDNF tran-
scripts during its actionondestabilizationof IHC/afferent contacts
during acoustic trauma, but not during BDNF-related retention
of the IHC/afferent contacts in the intact system, may be tested
in future studies. It has to be taken into consideration that the
deletion of CaV1.2 resulted in only 20–40% reduction of BDNF
transcripts in the cochlea. This may explain a milder protecting
phenotype than that found in the BDNFPax2 KO mice. However,
it cannot be ruled out that the protection against the noise-
induced damage, when CaV1.2 is deleted in the cochlea, is the
result of selective impact on only a subpopulation of cells or the
AN ﬁbers.
In conclusion we show that CaV1.2 deletion in the cochlea
affects mainly an AN ﬁber type with high-response thresholds.
Moreover, the current data demonstrate that the deletion of
CaV1.2 in the cochlea (CaV1.2Pax2 mice) rather than the deletion
of CaV1.2 in the SOC (CaV1.2Egr2 mice) can trigger a reduced
vulnerability to acoustic trauma-induced auditory ﬁber loss. We
provide evidence that this effect is linked to a CaV1.2 function on
maintaining expression of long or short BDNF transcripts, which
in the cochlea may drive destabilization of IHCs/afferent contacts
during acoustic trauma as already hypothesized in Zuccotti et al.
(2012). This destabilization of IHCs/afferents may originate from
a CaV1.2-related BDNF expression and release from supporting
cells after cochlear injury. Further studies are on the way to analyze
this aspect in more detail.
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